RUISEN LIFE SER (01922) received resumption guidance.

RUISEN LIFE SER (01922) issued an announcement on November 11, 2024, stating that the company received a letter from the Stock Exchange, which included guidelines for the resumption of trading of the company's shares on the Stock Exchange. According to the guidelines for resumption, the company must: (a) publish all financial performance that has not been published in accordance with the listing rules and address any audit revision opinions; (b) conduct an appropriate independent forensic investigation of the allegations, disclose the investigation results, assess the impact on the company's business operations and financial condition, and take appropriate remedial measures; (c) demonstrate the integrity, ability, and/or character of the group's management and/or any individuals who have a significant influence on the company's management and operations, as there may be reasonable regulatory concerns that could pose risks to investors and damage market confidence; (d) conduct an independent internal control review and demonstrate that the company has established adequate internal controls and procedures to fulfill its obligations under the listing rules; (e) demonstrate compliance with listing rule 13.24; (f) comply again with listing rule 13.92; and (g) disclose all significant information to the market for shareholders and other investors to assess the company's situation.